132 related articles for article (PubMed ID: 12084030)
1. Decreased production of insulin-like growth factor-binding protein (IGFBP)-6 by transfection of colon cancer cells with an antisense IGFBP-6 cDNA construct leads to stimulation of cell proliferation.
Kim EJ; Schaffer BS; Kang YH; Macdonald RG; Park JH
J Gastroenterol Hepatol; 2002 May; 17(5):563-70. PubMed ID: 12084030
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Caco-2 cell proliferation by all-trans retinoic acid: role of insulin-like growth factor binding protein-6.
Kim EJ; Kang YH; Schaffer BS; Bach LA; MacDonald RG; Park JH
J Cell Physiol; 2002 Jan; 190(1):92-100. PubMed ID: 11807815
[TBL] [Abstract][Full Text] [Related]
3. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation.
Park JH; Corkins MR; Vanderhoof JA; Caruso NM; Hrbek MJ; Schaffer BS; Slentz DH; McCusker RH; MacDonald RG
J Cell Physiol; 1996 Feb; 166(2):396-406. PubMed ID: 8592000
[TBL] [Abstract][Full Text] [Related]
4. Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I.
Singh P; Dai B; Dhruva B; Widen SG
Cancer Res; 1994 Dec; 54(24):6563-70. PubMed ID: 7527300
[TBL] [Abstract][Full Text] [Related]
5. Synthetic low-calcaemic vitamin D(3) analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells.
Oh YS; Kim EJ; Schaffer BS; Kang YH; Binderup L; MacDonald RG; Park JH
Mol Cell Endocrinol; 2001 Oct; 183(1-2):141-9. PubMed ID: 11604234
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition and differentiation of the human colon carcinoma cell line, Caco-2, by constitutive expression of insulin-like growth factor binding protein-3.
MacDonald RG; Schaffer BS; Kang IJ; Hong SM; Kim EJ; Park JH
J Gastroenterol Hepatol; 1999 Jan; 14(1):72-8. PubMed ID: 10029281
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the synthesis of insulin-like growth factor binding proteins and insulin-like growth factors in rat C6 glioma cells transfected with a gap junction connexin43 cDNA.
Bradshaw SL; Naus CC; Zhu D; Kidder GM; D'Ercole AJ; Han VK
Regul Pept; 1993 Oct; 48(1-2):99-112. PubMed ID: 7505471
[TBL] [Abstract][Full Text] [Related]
8. Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer.
Hochscheid R; Jaques G; Wegmann B
J Endocrinol; 2000 Sep; 166(3):553-63. PubMed ID: 10974650
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of mature insulin-like growth factor (IGF)-II leads to growth arrest in Caco-2 human colon cancer cells.
Kim EJ; Holthuizen PE; Kim J; Park JH
Growth Horm IGF Res; 2005 Feb; 15(1):64-71. PubMed ID: 15701574
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor regulation of human endometrial stromal cell function: coordinate effects on insulin-like growth factor binding protein-1, cell proliferation and prolactin secretion.
Irwin JC; de las Fuentes L; Dsupin BA; Giudice LC
Regul Pept; 1993 Oct; 48(1-2):165-77. PubMed ID: 7505463
[TBL] [Abstract][Full Text] [Related]
11. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II.
Singh P; Dai B; Yallampalli U; Lu X; Schroy PC
Endocrinology; 1996 May; 137(5):1764-74. PubMed ID: 8612513
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
Price WA; Moats-Staats BM; Stiles AD
Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
[TBL] [Abstract][Full Text] [Related]
13. Growth stimulation by transfection of intestinal epithelial cells with an antisense insulin-like growth factor binding protein-2 construct.
Corkins MR; Vanderhoof JA; Slentz DH; MacDonald RG; Park JH
Biochem Biophys Res Commun; 1995 Jun; 211(3):707-13. PubMed ID: 7541197
[TBL] [Abstract][Full Text] [Related]
14. Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation.
Kiess W; Koepf G; Christiansen H; Blum WF
Regul Pept; 1997 Sep; 72(1):19-29. PubMed ID: 9404729
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells.
Slootweg MC; Ohlsson C; Salles JP; de Vries CP; Netelenbos JC
Endocrinology; 1995 Oct; 136(10):4210-7. PubMed ID: 7545101
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines.
Höflich A; Lahm H; Blum W; Kolb H; Wolf E
FEBS Lett; 1998 Sep; 434(3):329-34. PubMed ID: 9742949
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human osteoblast marker gene expression by retinoids is mediated in part by insulin-like growth factor binding protein-6.
Yan T; Wergedal J; Zhou Y; Mohan S; Baylink DJ; Strong DD
Growth Horm IGF Res; 2001 Dec; 11(6):368-77. PubMed ID: 11914024
[TBL] [Abstract][Full Text] [Related]
18. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.
Han VK; Bassett N; Walton J; Challis JR
J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells.
Leng SL; Leeding KS; Whitehead RH; Bach LA
Mol Cell Endocrinol; 2001 Mar; 174(1-2):121-7. PubMed ID: 11306178
[TBL] [Abstract][Full Text] [Related]
20. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation.
Park JH; McCusker RH; Vanderhoof JA; Mohammadpour H; Harty RF; MacDonald RG
Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
